Clinical factors for choosing active surveillance: an analysis of papillary thyroid microcarcinoma patients with recurrence

被引:1
作者
Won, Ho-Ryun [1 ,2 ]
Kim, Min Gyu [1 ]
Kim, Min Soo [1 ]
Chang, Jae Won [1 ,3 ]
Koo, Bon Seok [1 ,3 ]
机构
[1] Chungnam Natl Univ, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Daejeon, South Korea
[2] Chungnam Natl Univ, Dept Otorhinolaryngol Head & Neck Surg, Sejong Hosp, Sejong, South Korea
[3] Chungnam Natl Univ Hosp, Dept Otolaryngol Head & Neck Surg, Daejeon, South Korea
基金
新加坡国家研究基金会;
关键词
thyroid cancer; papillary thyroid microcarcinoma; active surveillance; recurrence; clinical factor; BRAF MUTATION; CANCER; ASSOCIATION; CARCINOMA;
D O I
10.1530/ETJ-23-0195
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Active surveillance (AS) has been suggested as a management option for low-risk papillary thyroid microcarcinoma (PTMC). However, the currently proposed selection criteria for AS application do not consider various clinical factors. The purpose of this study was to analyze clinical factors related to recurrence that could be confirmed preoperatively in patients who underwent surgery for PTMC and to identify factors worth considering when deciding whether to apply AS. Materials and methods: Data were collected from patients with PTMC who underwent surgical treatment at Chungnam National University Hospital. A retrospective cohort was established according to the presence or absence of recurrence during the follow-up period. In total, 2717 patients were enrolled, of whom 60 experienced recurrence. Various clinical factors that could be identified before surgery were analyzed. Results: The relationship between various clinical factors that could be confirmed preoperatively and recurrence was confirmed through Cox regression analysis and Kaplan-Meier curve analysis. BRAF mutation and the tall cell variant were significantly more common in patients with recurrence. In patients aged 55 years or older, the risk of recurrence was lower than in younger patients, while the recurrence-free survival (RFS) rate was higher. Conclusion: When choosing between surgical treatment or AS in PTMC patients, additional consideration of the patient's clinical factors, such as age and BRAF mutation status, may be required in addition to the existing criteria.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] The contributing factors for lateral neck lymph node metastasis in papillary thyroid microcarcinoma (PTMC)
    Kim, Kwangsoon
    Zheng, Xiaojin
    Kim, Jin Kyong
    Lee, Cho Rok
    Kang, Sang-Wook
    Lee, Jandee
    Jeong, Jong Ju
    Nam, Kee-Hyun
    Chung, Woong Youn
    [J]. ENDOCRINE, 2020, 69 (01) : 149 - 156
  • [32] Marked Decrease Over Time in Conversion Surgery After Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma
    Sasaki, Takahiro
    Miyauchi, Akira
    Ito, Yasuhiro
    Kudo, Takumi
    Kanemura, Nobuaki
    Sano, Tsutomu
    Kawano, Shiori
    Yamamoto, Masatoshi
    Fujishima, Makoto
    Masuoka, Hiroo
    Higashiyama, Takuya
    Kihara, Minoru
    Miya, Akihiro
    [J]. THYROID, 2021, 31 (02) : 217 - 223
  • [33] Risk factors for skip metastasis in patients with papillary thyroid microcarcinoma
    Wu, Xin
    Li, Binglu
    Zheng, Chaoji
    He, Xiaodong
    [J]. CANCER MEDICINE, 2023, 12 (06): : 7560 - 7566
  • [34] Influencing Factors and Cumulative Risk Analysis of Cervical Lymph Node Metastasis of Papillary Thyroid Microcarcinoma
    Yin, Yirong
    Xu, Xiang
    Shen, Liyan
    Zhao, Wenjuan
    Diao, Hongcui
    Li, Chengqian
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [35] Active Surveillance May Be the Best Initial Management for Papillary Thyroid Microcarcinoma
    Ito, Yasuhiro
    Miyauchi, Akira
    [J]. JOURNAL OF THE ENDOCRINE SOCIETY, 2023, 7 (07)
  • [36] Active Surveillance as First-Line Management of Papillary Microcarcinoma
    Ito, Yasuhiro
    Miyauchi, Akira
    [J]. ANNUAL REVIEW OF MEDICINE, VOL 70, 2019, 70 : 369 - 379
  • [37] Molecular characterisation and clinical correlation of papillary thyroid microcarcinoma
    Sama, Maria Teresa
    Grosso, Enrico
    Mele, Chiara
    Laurora, Sara
    Monzeglio, Oriana
    Marzullo, Paolo
    Boldorini, Renzo
    Aluffi Valletti, Paolo
    Aimaretti, Gianluca
    Scatolini, Maria
    Pagano, Loredana
    [J]. ENDOCRINE, 2021, 71 (01) : 149 - 157
  • [38] Conservative Surveillance Management of Low-Risk Papillary Thyroid Microcarcinoma
    Miyauchi, Akira
    Ito, Yasuhiro
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2019, 48 (01) : 215 - +
  • [39] Choosing Optimal Microcarcinoma Patients for Active Surveillance Study (Compass): Effectiveness Evaluation of a Preoperative Clinical Framework
    Qian, Kai
    An, Ning
    Zhang, Mengmeng
    Guo, Kai
    Chen, Lili
    Xiang, Jun
    Wu, Yi
    Wang, Jun
    Guan, Haixia
    Wang, Zhuoying
    [J]. ENDOCRINE PRACTICE, 2021, 27 (09) : 912 - 917
  • [40] BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma
    Kim, Kyeong J.
    Kim, Sin G.
    Tan, Jie
    Shen, Xiaopei
    Viola, David
    Elisei, Rossella
    Puxeddu, Efisio
    Fugazzola, Laura
    Colombo, Carla
    Jarzab, Barbara
    Czarniecka, Agnieszka
    Lam, Alfred K.
    Mian, Caterina
    Vianello, Federica
    Yip, Linwah
    Riesco-Eizaguirre, Garcilaso
    Santisteban, Pilar
    O'Neill, Christine J.
    Sywak, Mark S.
    Clifton-Bligh, Roderick
    Bendlova, Bela
    Sykorova, Vlasta
    Xing, Mingzhao
    [J]. EUROPEAN JOURNAL OF CANCER, 2020, 124 : 161 - 169